In particular, ARF1, ARF4, ARF6 and ARL4 are aberrantly expressed in different types of cancer cells and human cancers, (e.g., breast, gastric, prostate and lung cancer), and their expression is associated with higher grade tumors, suggesting that these ARF family proteins play a crucial role in cancer development. Here, CDKN2A is linked to lung carcinoma.